首页> 外国专利> DIAGNOSTIC AND THERAPEUTIC TARGETS IN HUMAN HER2-POSITIVE BREAST CANCER

DIAGNOSTIC AND THERAPEUTIC TARGETS IN HUMAN HER2-POSITIVE BREAST CANCER

机译:人HER2阳性乳腺癌的诊断和治疗靶标

摘要

A method of analyzing tissue in a subject having or suspected of having cancer includes obtaining an expression profile from a sample of tissue obtained from the subject, wherein the expression profile comprises the level of at least one esophageal adenocarcinoma associated lincRNA selected from the group consisting of linc-PRKD, lincRTL, lincMIA, lincNAV, and lincTMEM.
机译:一种在患有或怀疑患有癌症的受试者中分析组织的方法,包括从获自该受试者的组织样品中获得表达谱,其中所述表达谱包括选自以下的至少一种食道腺癌相关的lincRNA的水平: linc-PRKD,lincRTL,lincMIA,lincNAV和lincTMEM。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号